Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 22679336)

1.

Marker-of-self becomes marker-of-senescence.

Sosale N, Discher DE.

Blood. 2012 Jun 7;119(23):5343-4. doi: 10.1182/blood-2012-04-418608. No abstract available.

2.

CD47 functions as a molecular switch for erythrocyte phagocytosis.

Burger P, Hilarius-Stokman P, de Korte D, van den Berg TK, van Bruggen R.

Blood. 2012 Jun 7;119(23):5512-21. doi: 10.1182/blood-2011-10-386805. Epub 2012 Mar 16.

3.

Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.

Tsai RK, Rodriguez PL, Discher DE.

Blood Cells Mol Dis. 2010 Jun 15;45(1):67-74. doi: 10.1016/j.bcmd.2010.02.016. Epub 2010 Mar 17.

4.

On the origin and function of immune 'self' recognition.

van den Berg TK.

Immunol Lett. 2010 Jan 18;128(1):24-5. doi: 10.1016/j.imlet.2009.09.013. Epub 2009 Oct 4. Review. No abstract available.

PMID:
19808051
5.

High-Affinity SIRPα Variants Potentiate Antibody Therapy Efficacy.

[No authors listed]

Cancer Discov. 2013 Jul;3(7):716. doi: 10.1158/2159-8290.CD-RW2013-124. Epub 2013 Jun 6.

6.

Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system.

Okazawa H, Motegi S, Ohyama N, Ohnishi H, Tomizawa T, Kaneko Y, Oldenborg PA, Ishikawa O, Matozaki T.

J Immunol. 2005 Feb 15;174(4):2004-11.

7.

The CD47 pathway is deregulated in human immune thrombocytopenia.

Catani L, Sollazzo D, Ricci F, Polverelli N, Palandri F, Baccarani M, Vianelli N, Lemoli RM.

Exp Hematol. 2011 Apr;39(4):486-94. doi: 10.1016/j.exphem.2010.12.011. Epub 2011 Jan 4.

PMID:
21211546
8.

Role of CD47 as a marker of self on red blood cells.

Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP.

Science. 2000 Jun 16;288(5473):2051-4.

9.

A new way to keep immune cells in check.

Hagmann M.

Science. 2000 Jun 16;288(5473):1945-6.

PMID:
10877706
10.

Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation.

van den Berg TK, van der Schoot CE.

Trends Immunol. 2008 May;29(5):203-6. doi: 10.1016/j.it.2008.02.004. Epub 2008 Apr 3. Review.

PMID:
18394962
11.

Novel structural determinants on SIRP alpha that mediate binding to CD47.

Lee WY, Weber DA, Laur O, Severson EA, McCall I, Jen RP, Chin AC, Wu T, Gernert KM, Parkos CA.

J Immunol. 2007 Dec 1;179(11):7741-50. Erratum in: J Immunol. 2008 Jan 1;180(1):665. Gernet, Kim M [corrected to Gernert, Kim M].

12.

Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.

Matozaki T, Murata Y, Okazawa H, Ohnishi H.

Trends Cell Biol. 2009 Feb;19(2):72-80. doi: 10.1016/j.tcb.2008.12.001. Epub 2009 Jan 12. Review.

PMID:
19144521
13.

Erythrophagocytosis in sickle cell anemia: statistical evidence for a biological phenomenon.

Mamtani M, Sharma M, Amin M, Amin A, Jawahirani A, Kulkarni H.

Med Hypotheses. 2007;68(5):1065-70. Epub 2006 Nov 13.

PMID:
17097820
14.

The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.

Chao MP, Weissman IL, Majeti R.

Curr Opin Immunol. 2012 Apr;24(2):225-32. doi: 10.1016/j.coi.2012.01.010. Epub 2012 Feb 4. Review.

15.

Phagocytic signaling: you can touch, but you can't eat.

Kinchen JM, Ravichandran KS.

Curr Biol. 2008 Jun 24;18(12):R521-4. doi: 10.1016/j.cub.2008.04.058.

16.

Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes.

Guimont-Desrochers F, Beauchamp C, Chabot-Roy G, Dugas V, Hillhouse EE, Dusseault J, Langlois G, Gautier-Ethier P, Darwiche J, Sarfati M, Lesage S.

Int Immunol. 2009 Feb;21(2):167-77. doi: 10.1093/intimm/dxn135. Epub 2009 Jan 15.

17.

On the mechanism of CD47 targeting in cancer.

Zhao XW, Matlung HL, Kuijpers TW, van den Berg TK.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2843; author reply E2844-5. doi: 10.1073/pnas.1209265109. Epub 2012 Aug 24. No abstract available.

18.

Blocking CD47 to stop tumor growth.

Harrington M.

Lab Anim (NY). 2012 Apr 19;41(5):111. doi: 10.1038/laban0512-111b. No abstract available.

PMID:
22517079
19.

Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles.

Rodriguez PL, Harada T, Christian DA, Pantano DA, Tsai RK, Discher DE.

Science. 2013 Feb 22;339(6122):971-5. doi: 10.1126/science.1229568.

20.

Inhibitory signaling through signal regulatory protein-α is not sufficient to explain the antitumor activities of CD47 antibodies.

Soto-Pantoja DR, Miller TW, Frazier WA, Roberts DD.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2842; author reply E2844-5. doi: 10.1073/pnas.1205441109. Epub 2012 Aug 24. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk